Financhill
Sell
42

INM Quote, Financials, Valuation and Earnings

Last price:
$2.83
Seasonality move :
37.78%
Day range:
$2.70 - $2.95
52-week range:
$1.72 - $15.70
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.36x
P/B ratio:
0.59x
Volume:
11.8K
Avg. volume:
42.3K
1-year change:
-43.15%
Market cap:
$3.6M
Revenue:
$4.6M
EPS (TTM):
-$13.75

Earnings Data

Next earnings date for INM
May 14
2025
Most recent earnings per share
-$3.64
Missed by $3.64
(Feb 12/2025)
Consensus Estimate
--
(Feb 12/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

INM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/12/2025 Q4 -- $1.1M -$3.64 -- --
11/14/2024 Q3 -- $1.3M -$2.71 -- --
06/30/2024 Q2 -- $1.3M -$3.80 -- --
05/14/2024 Q1 $1.5M $1.2M -$3.60 -- --
02/13/2024 Q4 $1.1M $1.2M -$3.71 -- --
09/30/2023 Q3 $1.4M $901.9K -$15.24 -- --
06/30/2023 Q2 $2.3M $2.3M $5.60 -- --
03/31/2023 Q1 -- $1M -$12.00 -- --
12/31/2022 Q4 -- $469.8K -$18.20 -- --
09/30/2022 Q3 -- $320.8K -$81.20 -- --
06/30/2022 Q2 $744.6K $514.8K -$260.80 -$109.40 -$151.40
03/31/2022 Q1 -- $309.6K -$122.80 -- --
12/31/2021 Q4 -- $265.1K -$154.60 -- --
09/30/2021 Q3 -- -- -$123.40 -- --
06/30/2021 Q2 -- -- -$204.20 -- --
03/31/2021 Q1 -- -- -$205.00 -- --
12/31/2020 Q4 -- -- -$185.00 -- --
09/30/2020 Q3 -- -- -$155.00 -- --
06/30/2020 Q2 -- -- -$155.00 -- --
03/31/2020 Q1 -- -- -$195.00 -- --
12/31/2019 Q4 -- -- -$240.00 -- --
09/30/2019 Q3 -- -- -$270.00 -- --
06/30/2019 Q2 -- -- -$357.03 -- --
03/31/2019 Q1 -- -- -$247.15 -- --
12/31/2018 Q4 -- -- -$242.29 -- --
09/30/2018 Q3 -- -- -$255.42 -- --
06/30/2018 Q2 -- -- -$241.67 -- --
03/31/2018 Q1 -- -- -$127.77 -- --
12/31/2017 Q4 -- -- -$131.21 -- --
09/30/2017 Q3 -- -- -$133.01 -- --
06/30/2017 Q2 -- -- -$263.16 -- --
03/31/2017 Q1 -- -- -$123.73 -- --
12/31/2016 Q4 -- -- -$122.76 -- --
09/30/2016 Q3 -- -- -$125.50 -- --
06/30/2016 Q2 -- -- -$128.79 -- --
03/31/2016 Q1 -- -- -$127.11 -- --
12/31/2015 Q4 -- -- -$118.90 -- --
09/30/2015 Q3 -- -- -$122.91 -- --
06/30/2015 Q2 -- -- -$285.29 -- --

InMed Pharmaceuticals Earnings Questions

  • How Much did InMed Pharmaceuticals Generate in Revenue Last Quarter?

    InMed Pharmaceuticals reported $1.1M worth of top line sales in its most recent quarter.

  • Did InMed Pharmaceuticals Beat Earnings Last Quarter?

    InMed Pharmaceuticals announced earnings per share of -$3.64 which represents a miss of analyst forecast a -- per share.

  • Is InMed Pharmaceuticals Profitable?

    InMed Pharmaceuticals reported $460.9K that represents $0.65 per share over the last quarter.

  • What is the Analyst Consensus for InMed Pharmaceuticals EPS Next Year?

    InMed Pharmaceuticals's earnings are forecast to grow from -$20.20 per share to -- per share next year representing an increase of --.

  • When is InMed Pharmaceuticals's Earnings Date?

    InMed Pharmaceuticals's next earnings date is May 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?

The big picture trends in e‑commerce sales are clearly in…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
60
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 7

Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.

Buy
77
FARO alert for May 7

Faro Technologies [FARO] is up 34.66% over the past day.

Buy
63
SKX alert for May 7

Skechers USA [SKX] is down 0.07% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock